Medartis Holding AG

Swiss Stock Exchange MED.SW

Medartis Holding AG Price to Earnings Ratio (P/E) on January 14, 2025: 1,357.18

Medartis Holding AG Price to Earnings Ratio (P/E) is 1,357.18 on January 14, 2025, a -8.41% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Medartis Holding AG 52-week high Price to Earnings Ratio (P/E) is 1,674.18 on March 28, 2024, which is 23.36% above the current Price to Earnings Ratio (P/E).
Medartis Holding AG 52-week low Price to Earnings Ratio (P/E) is 942.76 on November 19, 2024, which is -30.54% below the current Price to Earnings Ratio (P/E).
Medartis Holding AG average Price to Earnings Ratio (P/E) for the last 52 weeks is 1,339.68.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Swiss Stock Exchange: MED.SW

Medartis Holding AG

CEO	Mr. Matthias Schupp
IPO Date	March 23, 2018
Location	Switzerland
Headquarters	Hochbergerstrasse 60E
Employees	860
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.

Key trends

Past 5 years